Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

BMS' Opdivo and Yervoy ace kidney cancer trial

BMS' Opdivo and Yervoy ace kidney cancer trial The FDA is concerned about the risk associated with combining PD-1/PD-L1 inhibitors such as Keytruda and Opdivo with Celgene's Pomalyst (pomalidomide) or Revlimid (lenalidomide), two widely-used

Takeda can't sway NICE on oral myeloma therapy Ninlaro

Takeda can't sway NICE on oral myeloma therapy Ninlaro It is indicated for use alongside Celgene's blockbuster immunomodulatory drug Revlimid (lenalidomide) and dexamethasone.

Celgene joins PD-1 race via partnership with BeiGene

Celgene joins PD-1 race via partnership with BeiGene BeiGene is also acquiring Celgene's commercial operations in Asia with the right to sell blood cancer therapies Revlimid (lenalidomide) and Vidaza (azacitidine) and Abraxane (albumin-bound paclitaxel) for pancreatic cancer -

FDA halts third Merck myeloma trial after patient deaths

FDA halts third Merck myeloma trial after patient deaths More patients taking Merck's drug died than those getting other treatment in the three trials, which all involved combinations of Keytruda with Celgene's Pomalyst (pomalidomide) and Revlimid (lenalidomide), two ... carfilzomib) - in heavily pre-treated

Merck suspends two Keytruda trials after patient deaths

Merck suspends two Keytruda trials after patient deaths Investigators to look at Keytruda with Pomalyst and Revlimid. Merck &Co has paused patient enrolment in two trials of Keytruda to allow investigators to explore reports of deaths among patients taking ... The two trials - KEYNOTE-183 and KEYNOTE-185 -

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics